MSB 0.91% $1.11 mesoblast limited

top asx 100 performer one year read on ...., page-2

  1. 220 Posts.
    Vinn, do you think this could be a negative for Meso as they could be seen as being ahead of competitors at the minute by following FDA approvals. Would this open up the market for others to enter without the same amount of background work?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.